Concepedia

Ruth Hartley

RH

Statistics

Publications

16

Citations

2.7K

H-Index

16

Active since

2013

Affiliations

University of Leicester(Current)

Novartis (Switzerland)

NIHR Leicester Biomedical Research Centre

University Hospitals of Leicester NHS Trust

University of Oxford

Ruth Hartley is an author at University of Leicester specializing in medicine, pharmacotherapy, and pulmonology.

Publications per year

2013–2024

16

Publications

16

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

Fevipiprant, a prostaglandin D 2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial

Sherif Gonem, Rachid Berair, Amisha Singapuri et al. · The Lancet Respiratory Medicine · 2016 · 248 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +8

1–5 of 16